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Abstract 
 
Recently, various physiological effects of the tea polyphenol catechin for 
improving diseases such as cancer, arteriosclerosis, hyperlipedimia, and osteoporosis 
have been reported. However, the physiological effect of catechin on bone metabolism 
remains unclear. We examined the physiological effect of (-)-epigallocatechin-3-gallate 
(EGCG), which is the main component of green tea catechin, on osteoblast development 
using the precursor cell line of osteoblasts, MC3T3-E1, and co-culture of the osteoblasts 
from mouse newborn calvaria and mouse bone marrow cells. Although EGCG did not 
affect the viability and proliferation of MC3T3-E1, EGCG inhibited the osteoblast 
differentiation. Furthermore, EGCG did not affect the mineralization of differentiated 
MC3T3-E1, and reduced osteoclast formation in co-culture. These results suggest that 
EGCG can effectively suppress bone resorption, and can be used as an effective 
medicine for the symptoms of osteoporosis. 
 
 
1. INTRODUCTION 
 
Recently, various physiological effects of the tea polyphenol catechin for 
improving diseases such as cancer, arteriosclerosis, hyperlipemia, and osteoporosis have 
been reported (McKay and Blumberg, 2002; Crespy and Williamson, 2004). Green tea 
contains catechins such as (-)-epigallocatechin-3-gallate (EGCG), 
(-)-epicatechin-3-gallate (ECG), (-)-epicatechin (EC) and (-)-epigallocatechin (EGC), 
with EGCG accounting for more than 50% of the total of catechins (Nagle et al., 2006). 
In mammals, EGCG has the effect of improving lifestyle-related diseases such as tumor, 
allergy and arteriosclerosis (McKay and Blumberg, 2002; Crespy and Williamson, 
2004). EGCG has various physiological functions such as the protection of DNA 
damage/methylation, suppression of protease activity, induction of apoptosis, and 
regulation of cell cycle and arrest, in the cell (Khan et al., 2006; Chen et al., 2008). 
Generally, although EGCG has strong anti-oxidant activity, it is difficult to explain the 
various physiological functions of catechin only by the anti-oxidization activity. 
Recently, Tachibana et al. (2004) reported that EGCG acted on a specific signaling 
pathway through binding to the 67 kDa laminin receptor (67LR). 
Tea polyphenol is known to mitigate osteoporosis as one of its physiological roles 
(Hegarty et al., 2000). Osteoporosis is caused by, for example, an imbalance of bone 
metabolism induced by the promotion of bone resorption due to a lack of estrogen 
during menopause (Saika et al., 2001). Usually, the amount of bone remains constant, as 
osteoblast-induced bone formation is balanced by bone resorption by osteoclasts, and 
the number and function of osteoclasts and osteoblasts are kept normal by the mutual 
interaction of these cells (Takahashi et al., 1988a; Jimi et al., 1996). For example, 
osteoblasts produce the colony stimulating factor-1 (CSF-1) and the 
differentiation-inducing factor, receptor activator of nuclear factor κB ligand (RANKL), 
and they act on the precursor of osteoclasts to promote the differentiation of osteoclast 
(Yoshida et al., 1990; Amano et al., 1998; Lacey et al., 1998; Yasuda et al., 1998). 
Moreover, the activated vitamin D3 (1, 25(OH)2D3), prostaglandin E2 and the 
parathyroid hormone act on osteoblasts, and control the differentiation of osteoclasts 
through the expression of RANKL (Takahashi et al., 1988a; Suda et al., 1999). On the 
other hand, osteoblasts differentiate from the mesenchymal stem cell under the 
stimulation of bone morphogenetic protein (BMP) (Katagiri and Takahashi, 2002). A 
mesenchymal stem cell may potentially differentiate into osteoblast, muscle cell or 
adipocyte. The differentiation of osteoblasts is led by the induction of expression of 
alkaline phosphatase (ALP) or bone matrix proteins such as type I collagen, osteocalcin 
(OCN) and osteopontin, under the action of the transcription factors runt-related 
transcription factor 2 (Runx2) and Osterix (Nakashima et al., 2002; Komori, 2005). 
Furthermore, the repression of the differentiation factor to muscle cell and adipocyte 
also leads to the differentiation to osteoblasts (Nakashima et al., 2002; Komori, 2005). 
To date, little has been known about the physiological role of EGCG, except the 
induction of osteoclast cell death (Nakagawa et al., 2002; Yun et al., 2007) and 
mineralization of osteoblasts (Takita et al., 2002; Vali et al., 2007). This report aims to 
elucidate the physiological role and molecular mechanism of tea catechin on bone 
metabolism. 
 
 
2. MATERIALS AND METHODS 
 
2.1 Expression plasmid 
The expression plasmid (pGEX-2TK-RANKL) for the soluble RANKL-GST fusion 
protein was a gift from Dr. Takeya at the University of Nara Institute of Science and 
Technology (Meiyanto et al., 2001; Ishida et al., 2002). 
 
2.2 Cell culture 
MC3T3-E1 cells (RIKEN Institute of Physical and Chemical Research cell bank, 
Tsukuba, Ibaraki, Japan) were cultured at 37 °C in 100-mm dishes in Minimum 
Essential Medium Alpha Medium (α-MEM) (Invitrogen, Carlsbad, CA, USA) 
containing 50 mg/L ascorbic acid, supplemented with 10% FBS (Sanko Junyaku, 
Chiyoda, Tokyo, Japan). MC3T3-E1 cells were spread at density of 3.2 × 104 cells/cm2 
in α-MEM (10% FBS) containing EGCG (Mitsui Nourin Co., Ltd., Minato, Tokyo, 
Japan), ECG (Mitsui Nourin), resveratrol (Wako Pure Chemical, Osaka, Japan), or 
N-Acetylcysteine (Sigma-Aldrich, St. Louis, MO, USA). 
We obtained bone marrow cells from femurs and tibiae of 6-week-old male mouse 
and osteoblasts from mouse newborn calvaria (Saitama Experimental Animal Supply, 
Katsushika, Saitama, Japan). Bone marrow cells and osteoblasts were spread in the 
same plate with α-MEM (10% FBS) at density of 2 × 105 cells/well and 2 × 104 
cells/well, respectively (co-culture). To stimulate the differentiation of osteoclast, these 
cells were cultured simultaneously on the same plate for 6 d under the stimulation of 
10-8 M 1, 25(OH)2D3 (Wako) (Takahashi et al., 1988a). On the other hands, osteoblasts 
were cultured solely for 6 d with 10-8 M 1, 25(OH)2D3, and bone marrow cells were 
cultured solely for 6 d with 100 ng/ml RANKL and 20 ng/ml CSF-1 (PeproTech Inc., 
Rocky Hill, NJ, USA). 
RAW264 cells (RIKEN) were cultured at 37°C in 100-mm dishes in Dulbecco's 
modified Eagle's medium (DMEM) (Sigma-Aldrich) supplemented with 10% FBS and 
1% MEM non-essential amino acid solution (NEAA) (Invitrogen). To induce osteoclast 
development, RAW264 cells were plated on a 96-well plate at 2 × 103 cells/well and 
cultured in α-MEM (10% FBS, 1% NEAA) containing 100 ng/mL RANKL for 5 d. 
 
2.3 ALP staining 
After the culture, cells were incubated with 100 µL of 4% paraformaldehyde at 
4 °C for 1 h. Each well was washed with distilled water, and then 100 µL of ALP stain 
solution (100 mM Tris-HCl [pH 8.4], 0.01% naphthol AS-MX phosphate 
[Sigma-Aldrich], 0.06% fast blue BB salt [Sigma-Aldrich]) was added to each well and 
incubated for 30 min (Chang et al., 2003). Cells were washed with distilled water and 
observed under an optical microscope. 
 
2.4 ALP activity assay 
After the culture, cells were washed with PBS. The enzyme activity of ALP was 
measured by directly adding 100 µL/well of ALP-assay-buffer (0.6 M diethanolamine, 
0.6 mM MgCl2, 0.1% Triton X-100, and 30 mM p-nitrophenylphosphate) to each well. 
After the incubation for 15 min at room temperature, the reaction was terminated by 
adding 50 µL/well of 3 M NaOH, and the absorbance was measured at 405 nm using 
microplate reader (Kodaira et al., 2006). The ALP activity was normalized to its protein 
concentration and represented as units per microgram of protein, with each unit of 
activity being defined as the amount of enzyme that produces 1 nmol 
p-nitrophenol/min. 
 
2.5 Cell viability and proliferation 
Dead cells were stained with trypan blue. MC3T3-E1 cells were cultured on 40-mm 
dishes for 48 h. Then, the culture medium was replaced with new medium containing 
EGCG and cultured for additional 48 h. After the culture, cells were washed with PBS, 
and then incubated with 1 mL of 0.25% trypan blue solution for 1 min. Cells were 
washed with PBS and observed under an optical microscope. 
Cell viability was determined by 3-(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl 
tetrazolium bromide (MTT) assay. MC3T3-E1 cells were plated on a 96-well plate at 2 
× 103 cells/well and cultured for 48 h. Then, the culture medium was replaced with new 
medium containing EGCG and cultured for additional 48 h. After the culture, cells were 
washed with PBS, MTT was added and incubated for additional 3 h. The product was 
dissolved in 0.04 N HCl in isopropanol, and the absorbance at 570 nm was measured. 
   Cell proliferation was analyzed by using BrdU Cell Proliferation Assay Kit 
(Merck, Whitehouse Station, NJ, USA). MC3T3-E1 cells were cultured with EGCG for 
24 h. Then, cells were incubated with BrdU for additional 6 h, and the absorbance at 
450-540 nm was measured. 
 
2.6 PCR analysis 
Cells were cultured on 40-mm dishes, and the total RNA was extracted by a 
standard acid-GTC-phenol extraction method (Chomczynski and Sacchi, 1987). The 
cDNA was synthesized by M-MLV Reverse Transcriptase (Takara Bio, Otsu, Shiga, 
Japan), and subjected for PCR using the following primers: 
G3PDH primers: 
G3PDH-S1 (5ʹ′-GACCCTTCATTGACCT-3ʹ′) 
G3PDH-A1 (5ʹ′-CCACCACCCTGTTGCTGT-3ʹ′) 
Osteocalcin (OCN) primers: 
mOCN-S1 (5ʹ′-AGTCCCACACAGCAGCTT-3ʹ′) 
mOCN-A1 (5ʹ′-AGCCGAGCTGCCAGAGTT-3ʹ′) 
Alkaline phosphatase (ALP) primers: 
mALP-S1 (5ʹ′-AGGGTGGACTACCTCTTA-3ʹ′) 
mALP-A1 (5ʹ′-GCCTGGTAGTTGTTGTGA-3ʹ′) 
Receptor activator of nuclear factor κB ligand (RANKL) primers: 
mRANKL-S1 (5ʹ′-GACATGTGCCACTGAGAA-3ʹ′) 
mRANKL-A1 (5ʹ′- TGACAAGTCTGAAGACTC-3ʹ′) 
Colony stimulating factor-1 (CSF-1) primers: 
mCSF1-S3 (5ʹ′- TCCTGCAGCAGTTGATCG-3ʹ′) 
mCSF1-A3 (5ʹ′- GCTGTTGTTGCAGTTCTTGG-3ʹ′) 
PCR was performed using following conditions; for G3PDH primers (95 °C for 5 
min; 18 or 19 cycles of 95 °C for 30 s, 55 °C for 1 min, 72 °C for 1 min; 72 °C for 7 
min), for other primers (94 °C for 5 min; 25–33 cycles of 94 °C for 30 s, 59 °C for 30 s, 
72 °C for 30 s; 72 °C for 7 min). 
 
2.7 Mineralization assay 
MC3T3-E1 cells were cultured for 10 d. Then, the culture medium was replaced 
with new medium containing 10 mM β-glycerophosphate and cultured for additional 10 
d. After the culture, cells were washed with PBS, and fixed with 70% EtOH for 1 h at 
room temperature. Cells were washed with distilled water, and 100 µL of 1% Alizarin 
Red S solution (Kanto Chemical Co., Inc.) was added to each well and incubated. After 
30 min incubation, cells were washed with distilled water. Then, the dye was dissolved 
in 100 µL of 100 mM cetylpyridinium, and absorbance was measured at 562 nm (Wang 
et al., 2007). 
 
2.8 TRAP staining 
Cells were washed with PBS, and cells were fixed by incubation with 100 µL of 
4% paraformaldehyde at 4 °C for 1 h. Each well was washed with distilled water, and 
then incubated with 100 µL of tartrate-resistant acid phosphatase (TRAP) solution (50 
mM sodium tartrate, 45 mM sodium acetate [pH 5.0], 0.01% naphthol AS-MX 
phosphate [Sigma-Aldrich], 0.03% fast red violet LB salt [Sigma-Aldrich]) for 10 min 
(Matsumoto et al., 2000). Cells were washed with water and observed under an optical 
microscope. 
 
2.9 Statistical analysis 
Results are expressed as mean ± standard deviation. Comparisons between groups 
were made by analysis of variance (ANOVA), and when significant, were examined by 
Tukey’s all-pairwise-comparison test. Differences were considered significant when P < 
0.05. Statistical analysis was performed using Excel 2004 (Microsoft, Redmond, WA, 
USA) with the add-in software Statcal 2 (Yanai, 2004). 
 3. RESULTS 
 
3.1 Effect of EGCG on differentiation of MC3T3-E1 cells 
MC3T3-E1 cells originally derived from mouse calvaria were used to investigate 
the physiological role of EGCG on the differentiation of osteoblasts (Kodama et al., 
1981). MC3T3-E1 cells were cultured in a medium containing the green tea catechin 
EGCG, ECG, red grape polyphenol resveratrol, or N-acetylcysteine for 10 d. The 
dyeing analysis of the ALP-positive cells by the ALP stain method revealed that the 
number of ALP-positive cells decreased by the stimulation of 10 µM EGCG and 10 µM 
ECG (Fig. 1A). On the other hand, there was almost no change in the cells treated with 
10 µM resveratrol. The ALP activity was reduced by the addition of EGCG and ECG, 
whereas resveratrol did not affect ALP activity (Fig. 1B (a)). Furthermore, 10 mM 
N-acetylcysteine, which has anti-oxidant activity, increased ALP activity (Fig. 1B (b)). 
Next, MC3T3-E1 cells were cultured in the presence of EGCG (0, 1, 2.5, 5, or 10 
µM) for 4 d, 7 d, and 10 d, and the ALP activity was measured. As shown in Figure 2A, 
EGCG reduced the ALP activity dose-dependently: 10 µM EGCG suppressed ALP 
activity to about 50% of the control. The influence of EGCG on the expression of 
osteoblast-specific gene was analyzed by RT-PCR. Both expressions of ALP and OCN 
decreased as a result of the addition of EGCG (Fig. 2B). These results revealed that tea 
catechin, especially EGCG, suppressed the differentiation of MC3T3-E1 cells. 
 
3.2 EGCG does not change the viability and proliferation of MC3T3-E1 cells 
Next, the effects of catechin (EGCG) on the viability or proliferation of MC3T3-E1 
cells were analyzed. First, the dead cells were dyed by trypan blue. Although trypan 
blue dyed most of the cells that had been treated by 100 mM H2O2, the trypan 
blue-positive cells were hardly detected under the treatment by 10 µM EGCG (Fig. 3A). 
Next, MC3T3-E1 cells were cultured in the medium containing EGCG (0, 1, 5, 10, 15, 
or 20 µM), and cell viability was analyzed by MTT assay. The MTT is converted into 
formazan by mitochondrial dehydrogenase in the viable cells. Measureing the 
absorbence of the dissolved formazan enables the calculation of the survival rate. As a 
result, EGCG (up to 20 µM) did not influence the survival rate of the cells (Fig. 3B). To 
determine the physiological effect of EGCG on cell proliferation, the BrdU proliferation 
assay was performed. The BrdU proliferation assay involves incorporation of BrdU into 
newly synthesized DNA strands of actively proliferating cells. Following partial 
denaturation of double stranded DNA, BrdU is detected immunochemically allowing 
the assessment of the population of cells which are actively synthesizing DNA. As 
shown in Fig. 3C, EGCG (0, 1, 2.5, 5, or 10 µM) did not change the incorporation of 
BrdU into MC3T3-E1 cells at all. These data suggested that EGCG specifically 
suppressed cell differentiation of osteoblasts without affecting cell proliferation or cell 
death. 
 
3.3 Effect of EGCG on physiological function of differentiated MC3T3-E1 cells 
Next, the physiological function of EGCG on differentiated osteoblasts was 
analyzed. MC3T3-E1 cells were cultured for 10 d to induce differentiation, then the 
differentiated cells were cultured for a further 10 d with EGCG (0, 1, 2.5, 5, or 10 µM). 
ALP analysis revealed that EGCG treatment had no effect on ALP activity in the 
differentiated cells at all (Fig. 4A). Next, the effect of EGCG on mineralization by 
osteoblasts was analyzed. The MC3T3-E1 cells cultured for 10 d were incubated for a 
further 10 d with 10 mM β-glycerophosphate and 10 µM EGCG to induce 
mineralization. Analysis by the Alizarine Red S stain method clarified that EGCG had 
no effect at all on mineralization in the differentiated MC3T3-E1 cells (Fig. 4B). These 
data do not contradict the result that EGCG had no influence on the cell proliferation 
and survival rate of MC3T3-E1 cells. The results suggested that EGCG did not affect 
ALP activity or mineralization in the differentiated osteoblasts. 
 
3.4 Effect of EGCG on osteoclast formation in co-cultured cells 
It is well known that osteoblasts induce the differentiation of osteoclasts through 
the production of RANKL and CSF-1 (Katagiri and Takahashi, 2002). Therefore, the 
influence of EGCG on the ability of osteoblasts to induce differentiation was analyzed 
by using co-culture of osteoblasts and the precursor of osteoclasts. The osteoblasts 
collected from the calvaria of mouse newborn and bone marrow cells collected from 
mouse tibia and femur were cultured simultaneously on the same plate under the 
stimulation of 1, 25(OH)2D3 to stimulate the differentiation of osteoclasts. The 
expression of TRAP is specific to osteoclasts. The dyeing analysis of the 
TRAP-positive cells by the TRAP-stain method was performed. The number of 
differentiated osteoclasts decreased by the treatment of 10 µM EGCG (Fig. 5A), and 
EGCG suppressed the formation of osteoclasts from the bone marrow cells cultured 
solely in the presence of RANKL and CSF-1 (Fig. 5A). So, we analyzed whether 
EGCG affects the induction of osteoclast differentiation through the action of 
osteoblasts. RT-PCR analysis of RANKL and CSF-1 in osteoblasts revealed that EGCG 
did not change the expression of RANKL or CSF-1 (Fig. 5B). In addition, RAW264 
cells were cultured in the medium containing EGCG (0, 1, 2.5, 5, or 10 µM) and 100 
ng/mL RANKL for 5 d. EGCG remarkably suppressed the formation of osteoclasts 
from RAW264 cells, too (Fig. 6A), and the number of osteoclasts was decreased by 
EGCG treatment (Fig. 6B). These results suggested that EGCG suppressed the 
development of osteoclasts in co-cultured cells, possibly through direct action on 
osteoclast precursor cells. 
 
 
4. DISCUSSION 
 
It has been reported some polyphenols have physiological actions on the regulation 
of bone metabolism. For example, red wine polyphenols, such as resveratrol and 
piceatannol, promoted the differentiation of osteoblasts and so on (Mizutani et al., 1998; 
Chang et al., 2006), and resveratrol and EGCG led to the cell death of osteoclasts 
(Nakagawa et al., 2002; Boissy et al., 2005; Yun et al., 2007). It is well known that 
these physiological actions are caused partially by the anti-oxidative effect of 
polyphenol, however, the molecular mechanism of these effects is not well understood. 
Therefore, we analyzed the physiological effects of EGCG on the differentiation of 
osteoblasts by using a precursor cell line of osteoblasts, MC3T3-E1, which was 
originally derived from mouse calvaria (Kodama et al., 1981). ALP activation decreased 
remarkably when tea catechin EGCG or ECG was added to the culture of MC3T3-E1 
(Fig. 1). EGCG suppressed the expression of mRNA of ALP and OCN which are 
specifically expressed in osteoblasts (Fig. 2B). On the other hand, because resveratrol 
did not reduce ALP activity at all (Fig. 1), it is suggested that osteoblast differentiation 
is suppressed by tea catechin specifically. Moreover, the anti-oxidant N-acetylcysteine 
increased ALP activity (Fig. 1B (b)). It was also reported that N-acetylcysteine 
promotes the differentiation of osteoblasts (Jun et al., 2008), and therefore EGCG may 
be involved in osteoblast differentiation by a mechanism other than its anti-oxidative 
action. Recently, Tachibana et al. (2004) reported that EGCG acted on the specific 
signaling pathway through binding to the 67 kDa laminin receptor. The signaling 
pathway of 67LR is known little, however, it is thought that extracellular 
signal-regulated kinase and myosin regulatory light chain possibly be involved in 
(Fujiwara et al., 2005; Umeda et al., 2005). Therefore, further investigation is necessary 
to analyze whether this laminin receptor is actually involved in the signal transduction 
of EGCG in osteoblasts. EGCG influenced neither the cell death of MC3T3-E1 nor cell 
survival rate (Figs. 3A, B). Since EGCG affected cell proliferation much less (Fig. 3C), 
it is possible that EGCG influences the differentiation of osteoblasts directly. 
Next, the effect of EGCG on the bone formation of osteoblasts was analyzed to 
clarify the role of EGCG in the function of osteoblasts. As a result, EGCG had no effect 
on ALP activity in the differentiated MC3T3-E1 cell (Fig. 4A). This result suggests that 
EGCG did not affect the enzymatic activity of ALP itself, either. Furthermore, the 
addition of EGCG to the differentiated MC3T3-E1 cell did not influence mineralization 
(Fig. 4B). These results suggest that EGCG has a suppressive effect on differentiation to 
the precursor cell of osteoblasts, although EGCG has little effect on differentiated 
osteoblasts. The osteoblasts lead to the differentiation of osteoclasts through the 
production of RANKL. The formation of osteoclasts was decreased by the addition of 
EGCG when the osteoblasts from the mouse calvaria and the mouse bone marrow cell 
were co-cultured (Fig. 5A). When EGCG was added to the single-culture of bone 
marrow cells, the number of osteoclasts decreased (Fig. 5A) and the mRNA expression 
of RANKL and CSF-1 was not changed (Fig. 5B), so it is possible that EGCG acts on 
the precursor of osteoclasts directly, resulting in the suppression of differentiation. In 
order to know the direct action of EGCG on osteoclast development, mouse RAW264, 
an osteoclast differentiation-inducible cell line, was used for analysis. The mouse 
RAW264, a macrophage-like monocyte cell line, can develop into osteoclast-like 
multi-nuclear cells under the stimulation of RANKL (Matsumoto et al., 2000; Ralph 
and Nakoinz, 1977). EGCG suppressed the osteoclast formation of RAW264 cells, too 
(Fig. 6). There are also reports that EGCG promotes the cell death of osteoclast cell 
lines (Nakagawa et al., 2002; Yun et al., 2007), suggesting that EGCG may promote cell 
death of osteoclasts or their precursor directly, thus reducing the number of osteoclasts. 
Judging from the previous data (Nakagawa et al., 2002; Yun et al., 2007), EGCG 
possibly acts on osteoclasts or their precursor cell directly, and suppresses the 
differentiation of osteoclasts. Furthermore, because EGCG suppressed the 
differentiation of osteoblasts, it is thought that EGCG restrains the number of 
osteoclasts by suppressing the new formation of osteoblasts, in vivo. Of course, the 
concentration of EGCG in the blood is critically important to know the physiological 
role of EGCG in living animals. So far, it has been reported that the concentration of 
EGCG rises to about 10 µM in the blood when a high dose EGCG is administered orally 
(Ullmann et al., 2003). In this study, we applied less than 10 µM of EGCG, suggesting a 
condition which is close to that of the living body. This indicates that EGCG can be 
used as an effective medicine against the symptoms of osteoporosis. 
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FIGURE LEGENDS 
 
Fig. 1. Effect of polyphenols on osteoblast differentiation. MC3T3-E1 cells were 
cultured in the presence of 10 µM EGCG, 10 µM ECG, 10 µM resveratrol (Res) or 10 
mM N-Acetylcysteine (NAC) for 10 d. (A) After the culture, cells were fixed by 4% 
paraformaldehyde solution and stained by ALP method. (B) Cells were incubated with 
ALP assay buffer and ALP enzyme activity was measured. An error bar shows standard 
error of the mean, n=5. Against a value of (-), ** indicates P < 0.01. 
 
Fig. 2. Effect of EGCG on osteoblast differentiation. (A) MC3T3-E1 cells were 
cultured in the presence of EGCG (0, 1, 2.5, 5, or 10 µM) for 4, 7, or 10 d, and ALP 
enzyme activity was measured. An error bar shows standard error of the mean, n=5. 
Against a value of 0 M on each culture period, ** indicates P < 0.01. (B) MC3T3-E1 
cells were cultured in the presence of 0 M (-) or 10 µM (+) EGCG for 1, 4, 7, or 10 d. 
Total RNA was extracted and RT-PCR was performed with specific primers for ALP 
(33 cycle), OCN (25 cycle), or G3PDH (19 cycle). 
 
Fig. 3. Effect of EGCG on cell viability and proliferation. (A) MC3T3-E1 cells were 
cultured for 48 h. Then, the cells were cultured in the medium containing 0 M or 10 µM 
EGCG for 48 h. As positive control, cells were treated with 100 mM H2O2 for 30 min. 
After the culture, cells were stained by trypan blue method. (×400 magnification, scale 
bar: 100µm)  (B) MC3T3-E1 cells were cultured for 48 h, and then, the cells were 
cultured additional 48 h in the medium containing EGCG (0, 5, 10, 15, or 20 µM). After 
the culture, cells were treated for MTT assay. The product was dissolved in 0.04 N 
HCl/isopropanol and absorbance at 570 nm was measured. Cell viability was calculated 
relative to value of 0 M. An error bar shows standard error of the mean, n=6. (C) 
MC3T3-E1 cells were cultured with EGCG (0, 1, 2.5, 5, or 10 μM) for 24 h. To 
analyze DNA synthesis, cells were incubated with BrdU for 6 h. An error bar shows 
standard error of the mean, n=6. 
 
Fig. 4. Effect of EGCG on differentiated osteoblasts. (A) MC3T3-E1 cells were 
cultured for 10 d. Then, the cells were cultured in the medium containing EGCG (0, 1, 
2.5, 5, or 10 µM) for additional 10 d. After the culture, the ALP enzyme activity was 
measured. An error bar shows standard error of the mean, n=5. (B) MC3T3-E1 cells 
were cultured for 10 d. Then, the culture medium was replaced with new medium 
containing 0 M (-) or 10 µM (+) EGCG and 10 mM β-glycerophosphate and cultured 
for additional 10 d. After the culture, cells were stained by Alizarin Red S. An error bar 
shows standard error of the mean, n=3. 
 
Fig. 5. Effect of EGCG on osteoclast formation in the co-cultured cells. (A) In the 
co-culture, mouse bone marrow cells (BM) and osteoblasts (OB) were cultured in the 
presence of 0 M (-) or 10 µM (+) EGCG and 10-8M 1, 25(OH)2D3 for 6 d. In the OB 
culture, OB were cultured in the presence of 0 M (-) or 10 µM (+) EGCG and 10-8M 1, 
25(OH)2D3 for 6 d. In the BM culture, BM were cultured in the presence of 0 µM (-) or 
10 µM (+) EGCG and 100 ng/mL RANKL and 20 ng/mL CSF-1 for 6 d. After the 
culture, cells were stained by TRAP method. TRAP-positive cells were observed (×100 
magnification, scale bar: 500µm). (B) Mouse osteoblast was cultured in the presence of 
0 M (-) or 10 µM (+) EGCG and 10-8M 1, 25(OH)2D3 for 1 d. Total RNA was extracted 
and RT-PCR was performed with specific primers for RANKL (28 cycle), CSF-1 (25 
cycle), and G3PDH (18 cycle). 
 
Fig. 6. Effect of EGCG on osteoclast differentiation. (A) RAW264 cells were cultured 
in the presence of 0 µM (-) or 10 µM (+) EGCG and 100 ng/mL RANKL for 5 d. After 
the culture, cells were stained by TRAP method. TRAP-positive cells were observed 
(×50 magnification, scale bar: 1mm). (B) RAW264 cells were cultured in the presence 
of EGCG (0, 1, 2.5, 5, or 10 µM) and 100 ng/mL RANKL for 5 d. The number of 
TRAP-positive multi-nuclear cells (MNC) with more than three nuclei were measured 
(cells/well). An error bar shows standard deviation of the mean, n = 6. Against a value 
of 0 M, * P < 0.05 and ** P < 0.01. 
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